Biogen Down Nearly 8%, Worst Performer in the Nasdaq 100 So Far Today -- Data Talk
16 July 2021 - 5:20AM
Dow Jones News
Biogen Inc. (BIIB) is currently at $324.58, down $27.48 or
7.81%
-- Would be lowest close since June 4, 2021, when it closed at
$286.14
-- On pace for largest percent decrease since Nov. 9, 2020, when
it fell 28.17%
-- Snaps a two day winning streak
-- Down 6.26% month-to-date
-- Up 32.56% year-to-date
-- Down 25.97% from its all-time closing high of $438.43 on
March 20, 2015
-- Up 16.11% from 52 weeks ago (July 16, 2020), when it closed
at $279.54
-- Down 21.73% from its 52-week closing high of $414.71 on June
10, 2021
-- Up 37.38% from its 52-week closing low of $236.26 on Nov. 9,
2020
-- Traded as low as $323.71; lowest intraday level since June 7,
2021, when it hit $286.00
-- Down 8.05% at today's intraday low; largest intraday percent
decrease since Nov. 9, 2020, when it fell as much as 32.12%
-- Second worst performer in the S&P 500 today
-- Worst performer in the Nasdaq 100 today
All data as of 2:57:10 PM
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 15, 2021 15:16 ET (19:16 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Apr 2024 to May 2024
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From May 2023 to May 2024